Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa

Background: Breast cancer is the third commonest cancer in women in Uganda. The majority of breast cancer patients in Uganda present with advanced disease. Many studies show that metastatic lesions frequently lodge in bones, lung and liver. Tumour hormone receptor status correlates with site of meta...

Full description

Bibliographic Details
Main Authors: Nabawanuka A, Galukande M, Nalwoga H, Gakwaya A
Format: Article
Language:English
Published: Surgical Society of Kenya 2018-10-01
Series:The Annals of African Surgery
Subjects:
Online Access:https://www.annalsofafricansurgery.com/metastatic-breast-cancer-and-hormon
_version_ 1819088764736110592
author Nabawanuka A
Galukande M
Nalwoga H
Gakwaya A
author_facet Nabawanuka A
Galukande M
Nalwoga H
Gakwaya A
author_sort Nabawanuka A
collection DOAJ
description Background: Breast cancer is the third commonest cancer in women in Uganda. The majority of breast cancer patients in Uganda present with advanced disease. Many studies show that metastatic lesions frequently lodge in bones, lung and liver. Tumour hormone receptor status correlates with site of metastatic lesions and survival among breast cancer patients. Objective: To determine the sites of metastatic breast lesions and how they relate to the hormonal receptor status. Methods: In this cross sectional descriptive study, 71 women with histologically confirmed incident breast cancer with metastases were analysed, their hormonal receptor status was determined. All patients underwent a chest X-ray, an abdominopelvic ultrasound scan and a bone scan. The χ² and t tests were used to compare variables for statistical differences. Results: The mean age of participants was 45 years. Most metastases were to bone 56% (40/71), of these 45% (32/71 ) tumours were exclusive to bone and 94% of these (30/32) were ER+ . Of the 13 (18% of all patients) who had metastases to the liver, 7 were exclusive to the liver, and 1 (14.%) was ER positive. Of the 30 (42 %) patients with lung metastases, 23 patients were exclusive to lungs and 9/30 (39%) were ER+. In all 68% (48/71) were ER+, and bone metastases were associated with ER positivity and low grade tumors. Conclusion: Breast metastases had a preponderance to bone in this largely premenopausal group of women and these tumors were mostly ER positive. In the absence of tests to determine ER status, empirical antihormonal therapy may be used.
first_indexed 2024-12-21T21:57:14Z
format Article
id doaj.art-22a27ca73c4b4f388c4ef74529c8ba31
institution Directory Open Access Journal
issn 1999-9674
2523-0816
language English
last_indexed 2024-12-21T21:57:14Z
publishDate 2018-10-01
publisher Surgical Society of Kenya
record_format Article
series The Annals of African Surgery
spelling doaj.art-22a27ca73c4b4f388c4ef74529c8ba312022-12-21T18:48:56ZengSurgical Society of KenyaThe Annals of African Surgery1999-96742523-08162018-10-01Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan AfricaNabawanuka A0Galukande M1Nalwoga H2Gakwaya A3College of Health Sciences, Makerere University, Kampala, Uganda.College of Health Sciences, Makerere University, Kampala, Uganda.College of Health Sciences, Makerere University, Kampala, Uganda.College of Health Sciences, Makerere University, Kampala, Uganda.Background: Breast cancer is the third commonest cancer in women in Uganda. The majority of breast cancer patients in Uganda present with advanced disease. Many studies show that metastatic lesions frequently lodge in bones, lung and liver. Tumour hormone receptor status correlates with site of metastatic lesions and survival among breast cancer patients. Objective: To determine the sites of metastatic breast lesions and how they relate to the hormonal receptor status. Methods: In this cross sectional descriptive study, 71 women with histologically confirmed incident breast cancer with metastases were analysed, their hormonal receptor status was determined. All patients underwent a chest X-ray, an abdominopelvic ultrasound scan and a bone scan. The χ² and t tests were used to compare variables for statistical differences. Results: The mean age of participants was 45 years. Most metastases were to bone 56% (40/71), of these 45% (32/71 ) tumours were exclusive to bone and 94% of these (30/32) were ER+ . Of the 13 (18% of all patients) who had metastases to the liver, 7 were exclusive to the liver, and 1 (14.%) was ER positive. Of the 30 (42 %) patients with lung metastases, 23 patients were exclusive to lungs and 9/30 (39%) were ER+. In all 68% (48/71) were ER+, and bone metastases were associated with ER positivity and low grade tumors. Conclusion: Breast metastases had a preponderance to bone in this largely premenopausal group of women and these tumors were mostly ER positive. In the absence of tests to determine ER status, empirical antihormonal therapy may be used.https://www.annalsofafricansurgery.com/metastatic-breast-cancer-and-hormonmetastatic breast cancerhormonal receptor status
spellingShingle Nabawanuka A
Galukande M
Nalwoga H
Gakwaya A
Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
The Annals of African Surgery
metastatic breast cancer
hormonal receptor status
title Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
title_full Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
title_fullStr Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
title_full_unstemmed Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
title_short Metastatic Breast Cancer and Hormonal Receptor Status among a Group of Women in Sub Saharan Africa
title_sort metastatic breast cancer and hormonal receptor status among a group of women in sub saharan africa
topic metastatic breast cancer
hormonal receptor status
url https://www.annalsofafricansurgery.com/metastatic-breast-cancer-and-hormon
work_keys_str_mv AT nabawanukaa metastaticbreastcancerandhormonalreceptorstatusamongagroupofwomeninsubsaharanafrica
AT galukandem metastaticbreastcancerandhormonalreceptorstatusamongagroupofwomeninsubsaharanafrica
AT nalwogah metastaticbreastcancerandhormonalreceptorstatusamongagroupofwomeninsubsaharanafrica
AT gakwayaa metastaticbreastcancerandhormonalreceptorstatusamongagroupofwomeninsubsaharanafrica